蔡俊超, 高怡生. 肿瘤的化学治疗 ⅩⅩⅧ.若干哌嗪羧酸的N,N'-双取代衍生物的合成J. 药学学报, 1965, 12(1): 11-11.
引用本文: 蔡俊超, 高怡生. 肿瘤的化学治疗 ⅩⅩⅧ.若干哌嗪羧酸的N,N'-双取代衍生物的合成J. 药学学报, 1965, 12(1): 11-11.
TSAI TSEIN-CHAO AND KAO YEE-SHENG, . TUMOUR CHEMOTHERAPY ⅩⅩⅧ.SYNTHESIS OF SOME N,N'-BISSUBSTITUTED PIPERAZINE CARBOXYLIC ACID DERIVATIVESJ. Acta Pharmaceutica Sinica, 1965, 12(1): 11-11.
Citation: TSAI TSEIN-CHAO AND KAO YEE-SHENG, . TUMOUR CHEMOTHERAPY ⅩⅩⅧ.SYNTHESIS OF SOME N,N'-BISSUBSTITUTED PIPERAZINE CARBOXYLIC ACID DERIVATIVESJ. Acta Pharmaceutica Sinica, 1965, 12(1): 11-11.

肿瘤的化学治疗 ⅩⅩⅧ.若干哌嗪羧酸的N,N'-双取代衍生物的合成

TUMOUR CHEMOTHERAPY ⅩⅩⅧ.SYNTHESIS OF SOME N,N'-BISSUBSTITUTED PIPERAZINE CARBOXYLIC ACID DERIVATIVES

  • 摘要: HN2(I)或双(2-氯乙基)胺(Ⅲ)均易转化成哌嗪型化合物(Ⅱ)或(Ⅳ),后者对肿瘤也具有抑制作用。从结构看(Ⅳ)可当作以哌嗪为载体的烷化剂.作者鉴于哌嗪羧酸(Ⅵ)具有两性性质,可能溶解性能较好,乃以(Ⅵ)作为一些可能具有抗肿瘤作用基团的载体,合成了化合物Ⅶa-j, Ⅷa-m共23个化合物作抗动物肿瘤试验之用.化合物中Ⅷ1在组织培养试验中对HeLa细胞略有抑制作用.

     

    Abstract: In veiw of the facts that HN2(Ⅰ) can be selfcondensed to form piperazine derivative (Ⅱ) by chemical means and N,N'-bis(2-chloroethyl)amine (Ⅲ) to N,N'-bis(2-chloroethyl) piperazine (Ⅳ), the latter, though with two chloroethyl groups attached to different nitrogen atoms, still possesses inhibitory action towards the growth of sarcoma M45. Recently, some piperazine derivatives (Ⅴ) were reported to possess inhibitory action against many experimental tumours, and have been subjected to clinical trials. In this investigation, the authors utilized piperazine carboxylic acid, in view of its amphoteric nature, as the carrier of some antitumour groupings, hoping that the com- pounds thus obtained might possess more favourable antitumour activities and lower toxicities. The synthesis of ten N,N'-bissubstituted piperazine carboxylic acids and thir- teen related esters were described. N,N'-bis(benzenesulphonyl or tosyl) ethylenediamine condensed with methyl 2,3- dibromopropionate in the presence of sodium carbonate or triethylamine in methanol to give methyl N,N'-bis(benzenesulphonyl or tosyl)piperazine carboxylate (Ⅷ2 or Ⅷe) in high yields. The latter was treated with the following procedure: (1) By heating with concentrated hydrochloric acid in a sealed tube to give piperazine carboxylic acid dihydrochloride (VI·2HCl), which was then reacted with an appropriate acid chloride by employing the Schotten-Baumann reaction to give compounds Ⅶa-b,f-h. Ⅶf-hwere then converted to methyl or ethyl esters (Ⅷ1-m) by using diazomethane or diazoethane. Compound Ⅵ dihydrochloride was treated with ion exchange resin (Zerolite E) to afford Ⅵ, which was then formylated with formic acetic anhydride to give N,N'-bis(formyl) piperazine carboxylic acid Ⅶe. (2) By heating with a mixture of hydrochloric acid and glacial acetic acid or 10% potassium hydroxide solution to give N,N'-bis(benzenesul- phonyl or tosyl)piperazine carboxylic acid (Ⅶi or Ⅶj), which was first converted to acid chloride (X2 Or Xb) by thionyl chloride and then treated with suitable alcohol, to afford the corresponding esters of N,N'-bis(benzenesulphonyl or tosyl)piperazine carboxy- lic acid (Ⅷb-d,f-h). (3) By treating with 37% hydrogen bromide in glacial acetic acid to give methyl piperazine carboxylate dihydrobromide (Ⅺ), which can also be con- verted to compound Ⅷi by employing the Schotten-Baumann reaction. Among these compounds, only Ⅷj showed a moderate inhibition against HeLa cell in vitro. The animal test is in progress. An unsuccessful attempt was made to prepare N,N'-bis(2-chloroethyl)piperazine car- boxylic acid (Ⅻ).

     

/

返回文章
返回